Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism CDH11 inhibitors(Cadherin-11 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 2 | IT | 22 Dec 2016 | |
Rheumatoid Arthritis | Phase 2 | ES | 22 Dec 2016 | |
Rheumatoid Arthritis | Phase 2 | MX | 22 Dec 2016 | |
Rheumatoid Arthritis | Phase 2 | DE | 22 Dec 2016 | |
Rheumatoid Arthritis | Phase 2 | AT | 22 Dec 2016 | |
Rheumatoid Arthritis | Phase 2 | CO | 22 Dec 2016 | |
Rheumatoid Arthritis | Phase 2 | AR | 22 Dec 2016 | |
Rheumatoid Arthritis | Phase 2 | PE | 22 Dec 2016 | |
Rheumatoid Arthritis | Phase 2 | GB | 22 Dec 2016 | |
Rheumatoid Arthritis | Phase 2 | GT | 22 Dec 2016 |
Phase 2 | Rheumatoid Arthritis anti-TNFα therapy | 109 | (ngcxansgtc) = qiajbtdufd srtahfxpob (jlhmidiztp ) View more | Negative | 12 Jun 2019 | ||
Placebo | (ngcxansgtc) = abscllpeiw srtahfxpob (jlhmidiztp ) View more |